Active Ingredient(s):Miltefosine FDA Approved: * March 19, 2014 Pharm Company: *PALADIN THERAPEUTICS INC Category:Antiprotozoal / Anthelmintic
Miltefosine, sold under the trade name Impavido among others, is a medication mainly used to treat leishmaniasis and free-living amoeba infections such as Naegleria fowleri and Balamuthia mandrillaris. This includes the three forms of leishmaniasis: cutaneous, visceral and mucosal. It may be used with liposomal amphotericin B or paromomycin. It is taken by mouth.
Common side effects include vomiting, abdominal pain, f...
* May have multiple approval dates, manufacturers, or labelers.